**UPDATE Jan. 15, 2022**

It appears HELP Committee votes 13-8 in favor of Califf’s return to the agency despite Bog Pharma ties.  Well, he’ll be in good company with all the rest who have Big Pharma ties…..


Biden’s Pick for FDA Chief Formerly Worked as a Big Pharma Consultant, Has Millions in Big Pharma Investments

By B.N. Frank

The Food and Drug Administration (FDA) is supposed to protect Americans from unsafe products.  They have a long history of not doing so.  One glaring example, earlier this year, the agency approved an Alzheimer’s drug that:

Recently the drug company cut the price for the controversial drug in half.  But I digress.

Decisions that benefit industries while putting Americans at risk seem to be the norm at the FDA.  Experts continue to blame the agency for significantly contributing to the Opioid Crisis.  Nevertheless, Biden’s pick for the new chief has considerable ties to Big Pharma and it’s not going unnoticed. (See link for article)



  • Dr. Robert Califf was FDA commissioner during the last year of the Obama administration.
  • According to the article he “skated” through a congenial Senate confirmation hearing on Tuesday with the only stumble occurring when pressed about the FDA’s role and failings in the opioid crisis.
  • Califf has made millions as a consultant for more than a dozen pharmaceutical corporations and holds millions more in pharmaceutical investments (at least 8 million).
  • Nine out of the last 10 FDA commissioners went on to work for Big Pharma or serve on a prescription drug company’s board of directors.
  • Go to top link for the senate confirmation hearing.

For more: 

%d bloggers like this: